Atrandi Biosciences
PrivateLast Round
Series A
Feb 19, 2025
Total Funding Raised
$31M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Atrandi Biosciences is a biotechnology company that develops next-generation single-cell analysis technology, including microfluidic platforms and semi-permeable capsule (SPC) solutions for life sciences research.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atrandi Biosciences Comparables
Compare Atrandi Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Singleron Biotechnologies | 81% | |
| Mission Bio | 80% | |
| BioSkryb Genomics | 78% | |
Atrandi Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 19, 2025 | ||||
| Seed | Mar 23, 2023 | ||||
| Seed | Jan 27, 2021 |
Key People
Founding team and executive leadership
Atrandi Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metaplanet Holdings | Series A, Seed |
| Practica Capital | Series A, Seed |
| Lux Capital | Series A |
| Vsquared Ventures | Series A, Seed |
| GRIDS Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 36, representing 46% of headcount.
- Jul 13, 2026
Open roles increased to 24, representing 30% of headcount.
Atrandi Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Atrandi Biosciences's valuation, stock price, and market status.